Paras Healthcare, an Indian healthcare provider, submits its Draft Red Herring Prospectus to SEBI to float its ?1800 crore Initial Public Offering (IPO).
As per the draft papers, the firm is planning to raise ?500 crore via a fresh issue and up to ?1,300 crore via an Offer-for-Sale component by promoter Dr. Dharminder Kumar Nagar and investor-selling shareholders.
The proceeds raised from the fresh issue will be used towards the debt repayment of the existing borrowings and those of the wholly owned subsidiary, and for general corporate purposes.
According to the DRHP, with the launch of this IPO, the firm is looking to acquire the benefits of listing on the stock exchanges, improve its brand visibility and image, and attract investors to be a part of the company.
The book-running lead managers to the issue are BofA Securities India, JM Financial, and Nuvama Wealth Management, while MUFG Intime India is the registrar to the IPO.
Paras Healthcare is a clinical hospitality-led platform that offers advanced and highly specialised medical treatments through expert doctors and specialised departments. As of March 2026, the firm operates 8 hospitals with a bed capacity of 2211 beds across North India, Bihar, and Jharkhand.
Moreover, the company is planning to expand its hospital network by a 300-bed hospital in Gurugaon by FY2027 and a 500-bed hospital in Ludhiana by FY2028, expecting its bed capacity to reach 3,011 beds by March 31, 2028.
Over the last 3 years, the company has shown strong growth in revenue and profits, generating ?1,605.95 crore in FY26 and achieving an EBITDA margin of 20.60%.
Paras Healthcare IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | To be Updated Soon |
Paras Healthcare Company Financial Report
Amount ? in Crores
| Period Ended | Revenue | Expense | Profit After Tax |
| 2024 | ?1151.02 | ?1144.39 | ?15.33 |
| 2025 | ?1314.21 | ?1364.24 | ?57.98 |
| 2026 | ?1628.78 | ?1552.75 | ?43.83 |
Paras Healthcare IPO Valuation – FY2026
Paras Healthcare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ?4.34 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 12.98% |
| Net Asset Value (NAV): | ?39.11 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Aster DM Healthcare Limited | 7.53 | 95.90 | 9.70% | 88.32 | 4,643.22 Cr. |
| Apollo Hospitals Enterprise Limited | 135.04 | 60.02 | 21.95% | 657.58 | 25,228.50 Cr. |
| Fortis Healthcare Limited | 13.80 | 67.31 | 11.08% | 131.07 | 9,127.84 Cr. |
| Global Health Limited | 20.71 | 56.55 | 15.15% | 147.06 | 4,410.30 Cr. |
| Jupiter Lifeline Hospitals Limited | 29.59 | 43.98 | 13.41% | 235.50 | 1,499.79 Cr. |
| Krishna Institute of Medical Sciences Limited | 6.03 | 124.98 | 11.01% | 56.17 | 3,904.60 Cr. |
| Max Healthcare Institute Limited | 14.83 | 63.59 | 14.33% | 109.53 | 8,373.45 Cr. |
| Narayana Hrudayalaya Limited | 39.67 | 48.00 | 19.74% | 222.02 | 7,896.04 Cr. |
| Yatharth Hospital and Trauma Care Services Limited | 18.20 | 43.56 | 10.36% | 184.79 | 1,207.17 Cr. |
Objects of the Issue
- Prepayment or scheduled re-payment, in full or part, of certain outstanding borrowings availed by the Company
- Investment in the wholly owned Subsidiary, PMHPL (which also operates the hospital in Srinagar), for repayment/prepayment of borrowings, in full or part, of PMHPL
- General corporate purposes
IPO Lead Managers aka Merchant Bankers
- JM Financial Limited
- BofA Securities India Limited
- Nuvama Wealth Management Limited
Join the discussion
Please sign in to leave a comment or reply.